Luigi Claudio
Impact in
-
- Chemokine receptors and signaling
- Cancer-related Molecular Pathways
- CAR-T cell therapy research
-
- Heavy Metal Exposure and Toxicity
Papers in
- Surgery 5
- Genital Health and Disease 3
-
- Prostate Cancer Treatment and Research 2
- Renal cell carcinoma treatment 1
- Co-authors
- Pier Paolo Claudio (5 shared papers)Erik J. Tokar (1 shared paper)Anna Rita Volpe (1 shared paper)Marco Carmignani (1 shared paper)Pierpaolo Aimola (1 shared paper)Michael P. Waalkes (1 shared paper)Adrie van Bokhoven (1 shared paper)Marco Salvatore (2 shared papers)
- Journals
- Current Gene Therapy (1 paper)The Journal of Urology (1 paper)International Journal of Urology (1 paper)Current Cancer Drug Targets (1 paper)PLoS ONE (1 paper)
- Partner nations
- ItalyUnited StatesMalaysia
In The Last Decade
Luigi Claudio
12 papers receiving 361 citations
Peers
Comparison fields: 5 of 66
- Oncology 154
- Health, Toxicology and Mutagenesis 51
- Biotechnology 23
- Genetics 60
- Immunology 44
Countries citing papers authored by Luigi Claudio
This map shows the geographic impact of Luigi Claudio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Claudio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Claudio more than expected).
Fields of papers citing papers by Luigi Claudio
This network shows the impact of papers produced by Luigi Claudio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Claudio. The network helps show where Luigi Claudio may publish in the future.
Co-authors
The 25 scholars most cited alongside Luigi Claudio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 73 | |
| 2 | 2009 | 67 | |
| 3 | 2010 | 67 | |
| 4 | Expression of cell-cycle-regulated proteins pRb2/p130, p107, p27(kip1), p53, mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma. | 2002 | 62 |
| 5 | 2005 | 23 | |
| 6 | 2007 | 17 | |
| 7 | 2009 | 16 | |
| 8 | 1990 | 14 | |
| 9 | 2013 | 11 | |
| 10 | Intravesical chemo-immunotherapy in non muscle invasive bladder cancer. | 2013 | 10 |
| 11 | [Role of crural inguinal lymphadenectomy and dynamic sentinel lymph node biopsy in lymph node staging in squamous-cell carcinoma of the penis. Our experience]. | 2003 | 6 |
| 12 | 2005 | 2 |
About Luigi Claudio
Luigi Claudio is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Genetics and Molecular Biology, having authored 12 papers that have together received 368 indexed citations. Recurring topics across this work include Genital Health and Disease (3 papers), Prostate Cancer Treatment and Research (2 papers), Virus-based gene therapy research (2 papers), Multiple and Secondary Primary Cancers (1 paper), Viral Infectious Diseases and Gene Expression in Insects (1 paper), Cancer Mechanisms and Therapy (1 paper), Renal cell carcinoma treatment (1 paper) and Mercury impact and mitigation studies (1 paper). The work is most often cited by research in Oncology (154 citations), Health, Toxicology and Mutagenesis (51 citations), Biotechnology (23 citations), Genetics (60 citations) and Immunology (44 citations). Luigi Claudio has collaborated with scholars based in Italy, United States and Malaysia. Frequent co-authors include Pier Paolo Claudio, Erik J. Tokar, Anna Rita Volpe, Marco Carmignani, Pierpaolo Aimola, Michael P. Waalkes, Adrie van Bokhoven, Marco Salvatore, Sisto Perdonà and Adelaide Greco. Their work appears in journals such as Current Gene Therapy, The Journal of Urology, International Journal of Urology, Current Cancer Drug Targets and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.